Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Timing af primær kirurgi for ganespalte (TOPS)

11. august 2026 opdateret af: Kevin Munro

Dette forsøg er et randomiseret kontrolleret forsøg med et parallelt design, der finder sted i centre over hele Storbritannien, Skandinavien og Brasilien.

650 spædbørn med en diagnose af isoleret ganespalte, som anses for medicinsk egnet til operation efter 6 måneder, og som opfylder inklusionskriterierne, vil blive inkluderet i forsøget og randomiseret til at modtage enten:

  • Operation i en alder af 6 måneder, ELLER
  • Operation i en alder af 12 måneder.

Hovedformålet er at afgøre, om kirurgi for ganespalte, ved hjælp af en Sommerlad-teknik, i en alder af 6 måneder, sammenlignet med kirurgi ved brug af samme teknik i en alder af 12 måneder, forbedrer velopharyngeal funktion i en alder af 5 år. Alle spædbørn vil blive fulgt op i alderen 12 måneder, 3 år og fem år til vurdering af de primære resultater (i alderen 5 år) og sekundære resultater.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

Spædbørn vil blive fulgt op i alderen 12 måneder, 3 år og fem år. Ved hvert besøg vil følgende blive vurderet:

Alder 12 måneder

  • Taleudvikling (kanonisk pludren)
  • Audiologiske vurderinger
  • Vækst

Alder 3 år

  • Taleudvikling
  • Audiologiske vurderinger

Alder 5 år

  • Taleudvikling
  • Audiologiske vurderinger
  • Dentofacial udvikling (Blødt væv ANB og Maxillary arch constriction score ved hjælp af modificeret Huddart Bodenham-scoring)

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

558

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Bauru, Brasilien
        • University of Sao Paulo
      • Aarhus, Danmark
        • Århus Speech and Hearing Institute
      • Copenhagen, Danmark
        • Copenhagen Cleft Palate Centre
      • Belfast, Det Forenede Kongerige
        • Belfast Health And Social Care Trust
      • Birmingham, Det Forenede Kongerige
        • Birmingham Children's NHS Foundation Trust
      • Bristol, Det Forenede Kongerige
        • North Bristol NHS Foundation Trust
      • Edinburgh, Det Forenede Kongerige
        • Edinburgh Hospital for Sick Children
      • Glasgow, Det Forenede Kongerige
        • NHS Greater Glasgow and Clyde
      • Leeds, Det Forenede Kongerige
        • Leeds University Hospitals NHS foundation Trust
      • Liverpool, Det Forenede Kongerige, L12 2AP
        • Alder Hey Children's NHS Foundation Trust
      • Manchester, Det Forenede Kongerige, M13 9WL
        • Manchester University NHS Foundation Trust
      • Newcastle, Det Forenede Kongerige
        • Newcastle University Hospitals NHs Foundation Trust
      • Oxford, Det Forenede Kongerige
        • Oxford University Hospitals NHS Trust
      • Salisbury, Det Forenede Kongerige
        • Salisbury District Hospital
      • Swansea, Det Forenede Kongerige
        • Abertawe Bro Morgannwg University Health Board
      • Bergen, Norge
        • Helse Bergen HF
      • Oslo, Norge
        • Oslo University Hospital
      • Gothenburg, Sverige
        • Göteborg University
      • Linköping, Sverige
        • University of Linköping
      • Malmö, Sverige
        • Malmö University Hospital
      • Stockholm, Sverige
        • Karolinska University Hospital
      • Umeå, Sverige
        • Umeå University
      • Uppsala, Sverige
        • Uppsala University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

Ikke ældre end 6 måneder (Barn)

Tager imod sunde frivillige

Ingen

Beskrivelse

Inklusionskriterier:

  • Spædbørn med isoleret ganespalte
  • Medicinsk egnet til operation ved 6 måneder, korrigeret for gestationsalder
  • Skriftlig informeret fuldmagtssamtykke
  • En forælder/plejer har et modersmål i bopælslandet

Ekskluderingskriterier:

  • Samtykke ikke opnået
  • b. Spædbørn med syndromisk ganespalte (undtagen Van der Woude syndrom, som kan inkluderes, hvis hørelsen ikke er påvirket) eller alvorlig udviklingsforsinkelse
  • Medfødt sensorineuralt høretab eller mellemøreanomalier;
  • Variationen i den anatomiske præsentation er sådan, at den kirurg, der skal udføre proceduren, mener, at et trins lukning med Sommerlad-teknikken ville være uhensigtsmæssig;
  • Submukøs ganespalte (defineret af den klassiske triade af tegn, bifid, drøvle, knogledefekt i den hårde ganespalte, muskulær diastase, som beskrevet af Jensen et al (1988).
  • Hvor det sprog, der tales i hjemmet, ikke er majoritetssproget i bopælslandet.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: 12 måneders operation
Spædbørn vil blive primæropereret i en alder af 12 måneder ved hjælp af Sommerlad-teknik
Operation afsluttet med Sommerlad-teknikken
Eksperimentel: 6 måneders operation
Spædbørn vil blive primæropereret i en alder af 6 måneder ved hjælp af Sommerlad-teknik.
Operation afsluttet med Sommerlad-teknikken

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Insufficient Velopharyngeal Function
Tidsramme: 5 years of age
Measured by the Velopharyngeal Composite Score (VPC sum), which is a sum of scores, based on three components: hypernasality, non-oral errors, and VPI symptoms. Each component is scored between 0 and 2. The sum of the three scores gives the VPC sum (0-6). Scores ≥ 4 on this scale are considered insufficient (higher scores indicate a worse outcome). This outcome is measured as a dichotomous variable (insufficient or not insufficient) with a cut-off threshold of ≥ 4 to indicate insufficient. We report this as a percentage of participants that are assessed as having insufficient velopharyngeal function.
5 years of age

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Velopharyngeal Composite Score Summary (VPC Sum)
Tidsramme: 5 years of age

Measured by the Velopharyngeal Composite Score (VPC sum), which is a sum of scores, based on three components: hypernasality, non-oral errors, and VPI symptoms.

Each component is scored between 0 and 2. The sum of the three scores gives the VPC sum (0-6). Higher scores indicate increased severity.

5 years of age
Insufficient Velopharyngeal Function
Tidsramme: 3 & 5 years of age
Velopharyngeal function (VPC rate) measured on a 3 point scale; insufficient, marginal or sufficient. Scale is dichotomised into insufficient or marginal/sufficient (with lower score indicating insufficient). Reported as percentage of participants with insufficient function.
3 & 5 years of age
Velopharyngeal Insufficiency Symptoms
Tidsramme: 3 years of age
The percentage of times that a target consonant uttered has a VPI symptom
3 years of age
Canonical Babbling Present
Tidsramme: 1 year of age
Presence of canonical babbling of syllables
1 year of age
Canonical Babbling Ratio
Tidsramme: 1 year of age
The proportion of times that a syllable produced is "canonical"
1 year of age
Canonical Babbling Consonant Inventory
Tidsramme: 1 year of age
The number of unique consonants produced
1 year of age
Articulation: Percent Consonant Correct (PCC)
Tidsramme: 3 and 5 years of age
The percentage of times that a target consonant is uttered correct
3 and 5 years of age
Articulation: Percent Correct Placement (PCP)
Tidsramme: 3 and 5 years of age
Percentage of times that a target consonant has the correct place of articulation
3 and 5 years of age
Articulation: Percent Correct Manner (PCM)
Tidsramme: 3 and 5 years of age
Percentage of times that a target consonant has the correct manner of articulation
3 and 5 years of age
Articulation: Non-oral Consonant Errors
Tidsramme: 3 and 5 years of age
Percentage of times that a target consonant is realised as a non-oral error
3 and 5 years of age
Articulation: Oral Consonant Errors
Tidsramme: 3 and 5 years of age
Percentage of times that a target consonant is realised as an oral error
3 and 5 years of age
Postoperative/Long Term Complications: Dehiscence
Tidsramme: Up to 30 days postoperatively
Assessment for presence (indicated as yes on a dichotomized scale of yes/no) of postoperative/long term complication of dehiscence reported as percentage.
Up to 30 days postoperatively
Postoperative/Long Term Complications: Infection
Tidsramme: Up to 30 days postoperatively
A dichotomous outcome of whether the child has a postoperative infection (indicated as yes on a dichotomized scale of yes/no) reported as a percentage
Up to 30 days postoperatively
Postoperative/Long Term Complications: Evidence of Fistula
Tidsramme: Up to 5 years of age
Measured by assessment for presence (yes on a dichotomised scale of yes/no) for evidence of fistula, reported as percentage
Up to 5 years of age
Hearing Level: Abnormal Transient Otoacoustic Emission (TEOAE)
Tidsramme: 1 year of age
A dichotomous outcome of whether the child has abnormal TEOAE, reported percentage of participants that were abnormal.
1 year of age
Hearing Level: Abnormal Soundfield Audiometry
Tidsramme: 1 year of age
A dichotomous outcome of whether the child has abnormal sound field audiometry. Abnormal sound field audiometry is indicated by a measurement of >30 dB HL for at least one of four frequencies tested: 500 Hz, 1000 Hz, 2000 Hz or 4000 Hz. Reported as percentage of participants with abnormal outcome.
1 year of age
Hearing Level: Abnormal Puretone Audiometry in at Least One Ear.
Tidsramme: 3 and 5 years of age
A dichotomous outcome of whether the child has abnormal pure tone audiometry. If testing by pure tone audiometry is not possible, sound field audiometry can be used in its place. Abnormal audiometry in at least one ear is indicated by a measurement of >20 dB HL using the pure tone method, >25 dB HL for sound field, for at least one of four frequencies tested: 500 Hz, 1000 Hz, 2000 Hz or 4000 Hz.Reported as percentage of participants with abnormal outcome.
3 and 5 years of age
Hearing Level: Abnormal Puretone Audiometry in Both Ears
Tidsramme: 3 and 5 years of age
A dichotomous outcome defined in the same way as Abnormal Puretone Audiometry in at least one ear. For participants who have both ears tested and both tested ears indicate abnormal audiometry. Reported as percentage of participants with abnormal outcome.
3 and 5 years of age
Hearing Level: Severity of Better Ear
Tidsramme: 3 and 5 years of age
Severity of hearing loss is measured in better ear is categorised as normal, mild, moderate, severe or profound. Reported as percentage of participants with hearing outcome below normal
3 and 5 years of age
Middle Ear Function: Flat Line Tympanogram in at Least One Ear
Tidsramme: 1, 3 and 5 years of age
Middle ear function is assessed by presence of flat line Tympanogram in at least one ear. Reported as percentage of particpants with abnormal finding consistent with middle ear effusion.
1, 3 and 5 years of age
Middle Ear Function: Flat Line Tympanogram in Both Ears
Tidsramme: 1, 3 and 5 years of age
Middle ear function is assessed by presence of flat line Tympanogram in both ears. Reported as percentage of participants with abnormal outcome.
1, 3 and 5 years of age
Dentofacial Development: Soft Tissue ANB
Tidsramme: 5 years of age
The angle between soft tissue nasion, A point, and B point on a profile photograph. The unit of measure is angular degrees
5 years of age
Dentofacial Development: Maxillary Arch Constriction Score
Tidsramme: 5 years of age
Maxillary arch constriction score: a bounded continuous outcome, measured using the Huddart/Bodenham scoring system, on a maxilliary and mandibular arches impression. A score can range from -24 to 8. A positive score is good, with negative scores indicating maxillary constriction.
5 years of age
Growth: Nude Weight
Tidsramme: 1 year of age
Growth: Nude weight measured in kg
1 year of age
Growth: Crown to Heel Length
Tidsramme: 1 year of age
Measured in centimetres and recorded to one decimal place.
1 year of age
Growth: Occiptofrontal Circumference
Tidsramme: 1 year of age
Measured in centimetres and recorded to one decimal place.
1 year of age

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Kevin J Munro, University of Manchester

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juli 2010

Primær færdiggørelse (Faktiske)

1. august 2020

Studieafslutning (Faktiske)

26. marts 2021

Datoer for studieregistrering

Først indsendt

9. oktober 2009

Først indsendt, der opfyldte QC-kriterier

9. oktober 2009

Først opslået (Anslået)

12. oktober 2009

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

2. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

11. august 2026

Sidst verificeret

1. august 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 09-017-E
  • 1U01DE018837-01A1 (U.S. NIH-bevilling/kontrakt)
  • Sponsor Reference: 57201 (Anden identifikator: The University of Manchester (UK))
  • NIHR Portfolio Reference 30200 (Anden identifikator: NIHR)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

Data anonymised (participants and Speech and Language Therapists)

IPD-delingstidsramme

Immediately and up to 5 years after publication of the main paper

IPD-delingsadgangskriterier

Researchers who provide a methodologically sound proposal and ethical approval as appropriate

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner